TheReWalk Personal 6.0 System is designed for all day use at home and in the community. It is built to be customizable configured specifically for each user. (Photo courtesy of ReWalk Robotics Ltd.)

TheReWalk Personal 6.0 System is designed for all-day use at home and in the community. It is built to be customizable and configured specifically for each user. (Photo courtesy of ReWalk Robotics Ltd.)

An updated personal-powered exoskeleton system—the ReWalk Personal 6.0—was recently unveiled by Marlborough, Mass-headquartered ReWalk Robotics Ltd.

The new version of the ReWalk system is designed to offer those in the spinal cord-injured community a highly functional exoskeleton system with fast walking speed and precise fit among its key benefits. The ReWalk Personal 6.0 is described by a recent media release from the company as the latest version of the FDA-cleared exoskeleton, said to be appropriate for use at home and in the community.

“The launch of the 6.0 offers those with spinal cord injury an exoskeleton design that fits better, walks faster, and has better gait control than prior generations of the product,” says ReWalk’s CEO, Larry Jasinski. “Our design efforts are built on many years of user experience with a philosophy of offering an outstanding product for use in all aspects of everyday life.”

Jasinski notes in the media release that the enhanced design of the 6.0 offers highly customized fittings, and software to better match the size and anatomy of each individual user.

The Personal 6.0 System reportedly is fitted to the user’s measurements and custom ordered for each individual. It is also designed to enable users to walk at speeds up to 0.71 meters / second.

A removable backpack aims to eliminate weight from the shoulders, giving the user freedom for clothing choice and movement. The redesign of the strapping and padding was done to provide users an easier and faster capacity to put the system on and take it off.

“Our experience and feedback from daily use of the ReWalk systems in the community, combined with technical advances achieved by our R&D organization, have enabled this next-generation prosthetic exoskeleton,” said Jodi Gricci, VP of global marketing and training at ReWalk. “Our user evaluations with the 6.0 demonstrated the value of better fit, improved gait control, and more comfort with the removal of the backpack in this streamlined design.”

The company notes in its media release that ReWalk has FDA clearances for both its Personal and Rehabilitation systems. Likewise, it reports ReWalk Personal 6.0 systems are now available for purchase.

[Source: ReWalk Robotics Ltd]